These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31905090)
1. Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype. Furman DJ; White RL; Naskolnakorn J; Ye J; Kayser A; D'Esposito M J Cogn Neurosci; 2020 May; 32(5):804-821. PubMed ID: 31905090 [TBL] [Abstract][Full Text] [Related]
2. Enhancing dopamine tone modulates global and local cortical perfusion as a function of COMT val158met genotype. Furman DJ; Pappas I; White RL; Kayser AS; D'Esposito M Neuroimage; 2021 Nov; 242():118472. PubMed ID: 34390874 [TBL] [Abstract][Full Text] [Related]
3. Effects of tolcapone and bromocriptine on cognitive stability and flexibility. Cameron IGM; Wallace DL; Al-Zughoul A; Kayser AS; D'Esposito M Psychopharmacology (Berl); 2018 Apr; 235(4):1295-1305. PubMed ID: 29427081 [TBL] [Abstract][Full Text] [Related]
4. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Giakoumaki SG; Roussos P; Bitsios P Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698 [TBL] [Abstract][Full Text] [Related]
5. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739 [TBL] [Abstract][Full Text] [Related]
6. Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men. Valomon A; Holst SC; Borrello A; Weigend S; Müller T; Berger W; Sommerauer M; Baumann CR; Landolt HP Neuropsychopharmacology; 2018 Jun; 43(7):1599-1607. PubMed ID: 29472644 [TBL] [Abstract][Full Text] [Related]
7. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Schacht JP; Yeongbin Im ; Hoffman M; Voronin KE; Book SW; Anton RF Neuropsychopharmacology; 2022 Oct; 47(11):1953-1960. PubMed ID: 35523943 [TBL] [Abstract][Full Text] [Related]
8. Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex. Lapish CC; Ahn S; Evangelista LM; So K; Seamans JK; Phillips AG Psychopharmacology (Berl); 2009 Jan; 202(1-3):521-30. PubMed ID: 18854987 [TBL] [Abstract][Full Text] [Related]
9. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Ranganathan M; De Aquino JP; Cortes-Briones JA; Radhakrishnan R; Pittman B; Bhakta S; D'Souza DC Psychopharmacology (Berl); 2019 Nov; 236(11):3209-3219. PubMed ID: 31187152 [TBL] [Abstract][Full Text] [Related]
10. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats. Napolitano A; Bellini G; Borroni E; Zürcher G; Bonuccelli U Parkinsonism Relat Disord; 2003 Jan; 9(3):145-50. PubMed ID: 12573869 [TBL] [Abstract][Full Text] [Related]
11. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Schacht JP Pharmacogenomics J; 2016 Oct; 16(5):430-8. PubMed ID: 27241058 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic modulation of regional cerebral blood flow: An arterial spin labelling study of genetic and pharmacological manipulation of COMT activity. Martens M; McConnell FK; Filippini N; Mackay CE; Harrison PJ; Tunbridge EM Neuroimage; 2021 Jul; 234():117999. PubMed ID: 33789133 [TBL] [Abstract][Full Text] [Related]
13. Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism. Roussos P; Giakoumaki SG; Bitsios P Biol Psychiatry; 2009 Dec; 66(11):997-1004. PubMed ID: 19699472 [TBL] [Abstract][Full Text] [Related]
14. Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibility. Byers S; Buchler IP; DePasquale M; Rowley HL; Kulkarni RS; Pinder L; Kolobova A; Li C; Au V; Akuma D; Zhang G; Wei H; Cheetham SC; Barrow JC; Carr GV Psychopharmacology (Berl); 2020 Sep; 237(9):2695-2707. PubMed ID: 32474681 [TBL] [Abstract][Full Text] [Related]
15. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice. Detrait ER; Carr GV; Weinberger DR; Lamberty Y Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286 [TBL] [Abstract][Full Text] [Related]
16. Dopamine, time perception, and future time perspective. Mitchell JM; Weinstein D; Vega T; Kayser AS Psychopharmacology (Berl); 2018 Oct; 235(10):2783-2793. PubMed ID: 30027496 [TBL] [Abstract][Full Text] [Related]
17. Modulation of inhibition of return by the dopamine D2 receptor agonist bromocriptine depends on individual DAT1 genotype. Rokem A; Landau AN; Prinzmetal W; Wallace DL; Silver MA; D'Esposito M Cereb Cortex; 2012 May; 22(5):1133-8. PubMed ID: 21799208 [TBL] [Abstract][Full Text] [Related]